Quality of Life and Lung Function on Post Covid-19 Patient

Effect of Breathing Exercise on Chest Expansion, Quality of Life and Lung Function on Post Covid-19 Patient: A Randomized Controlled Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05172102

Acronym

Covid-19

Enrollment

Registered

2021-12-29

Start date

2021-12-20

Completion date

2023-03-30

Last updated

2023-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Brief summary

Gaining a greater understanding of how the breathing exercise combined with aerobic and strengthening exercises will affects lung function and quality of life in post covid-19 persons

Detailed description

this will improve exercise prescription guidelines relevant to this post covid-19. Therefore, the purpose of this work was determining the effect of breathing exercise combined with aerobic and strengthening exercises in improve chest expansion, lung function and quality of life in post covid-19 persons.

Interventions

OTHERbreathing exercise, Aerobic exercises

6 min of quiet breathing (3 sets of 2 min each), 6 min of diaphragmatic breathing (3 sets of 2 min each), 6 min of diaphragmatic breathing plus pursed-lips breathing (3 sets of 2 min each).

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 30 Years

Healthy volunteers

Inclusion criteria

* Female. Age from 20 to 30 years old. - Body mass index (BMI) 19 to 24 kg/m2.- Non-smoker- Recovered from COVID-19 over the past 12 months. - They are experiencing mild to moderate symptoms without any complications. - * Able to use online communication programs.

Exclusion criteria

* \- Anyone who does regular physical exercise. * history of acute illness, asthma, pulmonary fibrosis, hypertension, diabetes disease. * hypoxemia in rest.

Design outcomes

Primary

Measure	Time frame	Description
Health-related quality of life, Medical Outcomes Study short-form (SF-36)	at baseline	assessed using the Short Form-36 (SF-36). The SF-36 scale had 8 dimensions, and each dimension was converted into a percentage score.
Respiratory function measurement	at baseline	assessed by a spirometer. The following parameters related to respiratory function will be measured: (1) forced expiratory volume in 1 second (FEV1); (2) forced vital capacity (FVC).

Secondary

Measure	Time frame	Description
Chest expansion measurement	at baseline	measured with a tape measure at 2 different levels of the rib cage. Measurements will be taken at the maximal inspiration and expiration
Exercise endurance measurement	at baseline	measured by the 6-min walk test (6MWT), is the distance one walks within 6 min

Countries

Saudi Arabia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026